4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001062993-25-004813
Chief Financial Officer sold 10,320 shares at an average $6.98 ($72,072)
- Chief Financial Officer acquired 125,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
PISKEL KYLE · Chief Financial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-04 | Grant or award : show line 1 in the form | +125,000 | 279,330 | D | ||
| 2025-03-05 | Sale : show line 2 in the form | −3,103 | $6.97 | $21,628 | 276,227 | D |
| 2025-03-05 | Sale : show line 3 in the form | −253 | $6.98 | $1,766 | 275,974 | D |
| 2025-03-05 | Sale : show line 4 in the form | −6,964 | $6.99 | $48,678 | 269,010 | D |
| Open-market sales · 10,320 sh · avg $6.98 · $72,072 | ||||||
Loading xslF345X05/form4.xml…